Product Safety Recalls

Product Recall Tracker

Recall D-1303-2022

Description: Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL USA 33314, USA, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054 USA; NDC 58544-692-30.

Recall D-1303-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1303-2022
Event ID90635
DistributionNationwide in the USA and Puerto Rico
Quantity5677 bottles
Recall ReasonFailed Dissolution Specifications: below specification limits for dissolution.
Drug ClassificationClass II
Drug Code Info20220810
Recall Initiation Date20220721
Report Date20220810
Classification Date20220804
Address400 Interpace Pkwy Bldg A
Parsippany, NJ 07054-1120
United States
Recalling FirmTeva Pharmaceuticals USA Inc
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.